High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA.
about
Multidrug resistance in bacteriaNovel Conserved Genotypes Correspond to Antibiotic Resistance Phenotypes of E. coli Clinical IsolatesIntrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpAInsights into the environmental resistance gene pool from the genome sequence of the multidrug-resistant environmental isolate Escherichia coli SMS-3-5.Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar typhimurium DT204 acrB mutants selected with fluoroquinolones.Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes.Microbial efflux pump inhibition: tactics and strategies.Regulation of bacterial drug export systemsMechanism of action of and resistance to quinolones.Correlation of overexpression of efflux pump genes with antibiotic resistance in Escherichia coli Strains clinically isolated from urinary tract infection patients.Significance of biocide usage and antimicrobial resistance in domiciliary environments.Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteriaDetection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from TurkeyEvolution and spread of antibiotic resistance.AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis.Staphylococcus aureus but not Listeria monocytogenes adapt to triclosan and adaptation correlates with increased fabI expression and agr deficiencyAdaptive resistance in bacteria requires epigenetic inheritance, genetic noise, and cost of efflux pumpsEfflux-mediated antimicrobial resistance.Global fluoroquinolone resistance epidemiology and implictions for clinical use.Multidrug-resistance efflux pumps - not just for resistance.Structural and functional aspects of the multidrug efflux pump AcrB.Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli.AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104.Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.Emergence of antibiotic-resistant extremophiles (AREs).One ring to rule them all: Current trends in combating bacterial resistance to the β-lactamsMechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains.A MATE family multidrug efflux transporter pumps out fluoroquinolones in Bacteroides thetaiotaomicron.Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase productionAcrAB Efflux System: Expression and Contribution to Fluoroquinolone Resistance in Klebsiella spp.Metatranscriptomics reveals metabolic adaptation and induction of virulence factors by Haemophilus parasuis during lung infection.Glyconanomaterials for Combating Bacterial Infections.Role for tandem duplication and lon protease in AcrAB-TolC- dependent multiple antibiotic resistance (Mar) in an Escherichia coli mutant without mutations in marRAB or acrRAB.Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415.Expression of acrA and acrB Genes in Esherichia coli Mutants with or without marR or acrR Mutations.Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolateMechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates.Growth phase-dependent expression of drug exporters in Escherichia coli and its contribution to drug tolerance.
P2860
Q22255652-38C07010-3C80-4591-A487-0F453BF26FA3Q28534076-26FEFE91-B025-477E-9968-041CDD30CE5BQ32035273-8BB6DC7A-C4CD-4D22-B7A8-4A8B604835BCQ33360684-13FFD806-66C4-448B-9D26-19B49923BBE2Q33555483-17EE353E-0132-4EBE-B8E8-8621DE12598EQ33982113-44273879-C7F1-4EFB-A8AB-D1C57677DFA9Q34111927-27A04F16-CD68-40CA-B133-411D02E479BBQ34176211-C28485EC-9E36-4260-B135-A041A24EDB5FQ34300836-06360452-A535-49A8-BF78-27A79233FE18Q34408434-9771E846-93B1-42C8-B86A-6467310DAEC6Q34487416-420EAD05-72EB-4189-9C4E-C223453622A9Q34631484-7F06913A-4468-43A1-83A1-5100F8DA3878Q34647294-03B4B329-216B-4F84-B45D-F6C65CAF47E9Q34782401-C985AEA3-851E-4EDC-BC8B-330C597323B3Q34792403-FEA51F47-0038-4CDE-AEDF-4E1688CF580CQ34822277-49EAE3D5-F0A1-4AF3-8936-3744D720E4CAQ34880970-5E31BC0A-517F-4CF5-AFCC-9DA141C94FD7Q35579733-1DACFA13-4011-4071-BAAD-21F44C83AA05Q36138147-5E84DAB9-4F19-4D1D-9651-A57913582EE2Q36337074-114D203F-7D02-4D13-AABF-753F3730F519Q36538111-CD78F163-0DDF-4C8D-9E1D-32379899AB64Q37488259-D492D5B8-6EFB-40CA-B625-55570B63BD0AQ37489157-9D9FAB23-DDB2-4E14-B3E4-9E3A253A13D6Q37568948-78689D43-9EE9-4B2E-80F5-3BB6342D80FCQ38011247-C53D0685-BFFF-47A6-8F16-4D5C31E6D24BQ38036072-87A7C04D-08C8-4948-929A-C5AC4A560714Q38712471-A91B2AE7-4AD6-4948-BA72-15209DCEBC8DQ38724103-7FFD09BF-6F04-47E1-AA62-D874D447F35CQ39477696-B2F13AB1-7A17-4E83-A716-F0B755F635D3Q39479055-F910CCB0-3E22-49E2-A6C6-1D579E2C7E20Q39671025-13047725-6EA2-4B09-BD5C-2723C3405BCBQ39671070-252C05AF-591F-4F66-A985-C345513D1BEBQ40512825-B6ECCD4B-CA2D-4346-B968-CB01951E840BQ40975640-1A47B664-0956-4889-9AAF-5AEBC423B01AQ41669705-631BD4C6-85BF-4196-AC52-F6EDE1E8E425Q41778891-94BEDD42-9352-44D2-A3D0-9F1DD0D98ADAQ41975977-29FD8EB6-34A4-44F0-8D77-6B76DBE24B38Q42130215-8EFA4124-853E-485E-9CA9-FD46DAA22D4BQ42234726-689C0CCC-2640-4429-BEA9-5B1CDBB5AB9AQ42577973-9B4B485F-60E1-4BEB-A072-9269C2311549
P2860
High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
High-level fluoroquinolone-res ...... multidrug efflux protein AcrA.
@en
High-level fluoroquinolone-res ...... multidrug efflux protein AcrA.
@nl
type
label
High-level fluoroquinolone-res ...... multidrug efflux protein AcrA.
@en
High-level fluoroquinolone-res ...... multidrug efflux protein AcrA.
@nl
prefLabel
High-level fluoroquinolone-res ...... multidrug efflux protein AcrA.
@en
High-level fluoroquinolone-res ...... multidrug efflux protein AcrA.
@nl
P2093
P2860
P1476
High-level fluoroquinolone-res ...... multidrug efflux protein AcrA.
@en
P2093
A Mazzariol
G Cornaglia
T M Kanegawa
P2860
P304
P356
10.1128/AAC.44.12.3441-3443.2000
P407
P577
2000-12-01T00:00:00Z